PepGen, Inc. (PEPG) vs Sionna Therapeutics, Inc. (SION)

PepGen, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. PepGen, Inc. and Sionna Therapeutics, Inc. are of similar size ($184.5M and $175.2M). Across the 9 metrics below, Sionna Therapeutics, Inc. leads on 6 and PepGen, Inc. on 3.

Valuation

Metric PEPG SION Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.51 0.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.32 0.64
EV/Sales n/m n/m 9.21
Earnings yield (50.38%) (56.04%) (33.15%)
Free cash flow yield (38.63%) (43.44%) (25.50%)

Profitability

Metric PEPG SION Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (75.45%) (32.34%) (56.36%)
Return on assets (59.06%) (30.66%) (48.04%)
Return on invested capital (2,076.25%) (125.00%) 0.00%

Growth

Metric PEPG SION Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 25.61% 88.24% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PEPG SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.36 20.05 4.72
Net debt to EBITDA 1.64 2.58 0.96

Dividend

Metric PEPG SION Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PEPG SION Biotechnology median
Market cap 175.22m 184.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack